Acrinova Ab Series Stock Current Liabilities
ACRI-B Stock | SEK 9.02 0.06 0.66% |
Acrinova AB Series fundamentals help investors to digest information that contributes to Acrinova's financial success or failures. It also enables traders to predict the movement of Acrinova Stock. The fundamental analysis module provides a way to measure Acrinova's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Acrinova stock.
Acrinova |
Acrinova AB Series Company Current Liabilities Analysis
Acrinova's Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.
Current liabilities appear on the company's balance sheet and include all short term debt accounts, accounts and notes payable, accrued liabilities as well as current payments due on the long-term loans. One of the most useful applications of Current Liabilities is the current ratio which is defined as current assets divided by its current liabilities. High current ratios mean that current assets are more than sufficient to pay off current liabilities.
Competition |
In accordance with the recently published financial statements, Acrinova AB Series has a Current Liabilities of 0.0. This is 100.0% lower than that of the Real Estate sector and about the same as Real Estate—Diversified (which currently averages 0.0) industry. The current liabilities for all Sweden stocks is 100.0% higher than that of the company.
Did you try this?
Run Stock Screener Now
Stock ScreenerFind equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |
All Next | Launch Module |
Acrinova Fundamentals
Return On Equity | 0.11 | |||
Return On Asset | 0.0162 | |||
Profit Margin | 0.85 % | |||
Operating Margin | 0.40 % | |||
Current Valuation | 1.41 B | |||
Shares Outstanding | 41.01 M | |||
Shares Owned By Insiders | 40.16 % | |||
Shares Owned By Institutions | 19.30 % | |||
Price To Earning | 4.83 X | |||
Price To Book | 0.52 X | |||
Price To Sales | 4.41 X | |||
Revenue | 101.95 M | |||
Gross Profit | 79.84 M | |||
EBITDA | 205.44 M | |||
Net Income | 153.16 M | |||
Cash And Equivalents | 76.61 M | |||
Cash Per Share | 1.40 X | |||
Total Debt | 776.51 M | |||
Debt To Equity | 0.99 % | |||
Current Ratio | 1.77 X | |||
Book Value Per Share | 14.46 X | |||
Cash Flow From Operations | 79.9 M | |||
Earnings Per Share | 2.23 X | |||
Number Of Employees | 10 | |||
Beta | 0.55 | |||
Market Capitalization | 505.1 M | |||
Total Asset | 1.83 B | |||
Annual Yield | 0.05 % | |||
Net Asset | 1.83 B | |||
Last Dividend Paid | 0.2 |
About Acrinova Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Acrinova AB Series's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Acrinova using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Acrinova AB Series based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Other Information on Investing in Acrinova Stock
Acrinova financial ratios help investors to determine whether Acrinova Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Acrinova with respect to the benefits of owning Acrinova security.